Home GPCR & G Protein -Neuronal Signaling Melanocortin Receptor

Melanocortin Receptor

Choose Selective Melanocortin Receptor Inhibitors

Melanocortin Receptor Products

  • All (3)
  • Melanocortin Receptor Inhibitor (1)
  • Melanocortin Receptor Antagonist (1)
  • Melanocortin Receptor Agonist (1)
  • New Melanocortin Receptor Products
Catalog No. Product Name Information Product Use Citations Product Validations
P1108New Bremelanotide Acetate Bremelanotide Acetate (PT-141 Acetate) is a melanocortin receptor (MCR) agonist recently approved in the USA for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD), as characterized by low sexual desire that causes marked distress or interpersonal difficulty.
S0019 JNJ-10229570 JNJ-10229570 (UNII-N9IX402L35) is a potent MC1R and MC5R antagonist.
E1002New Setmelanotide (RM-493)

Setmelanotide (RM-493, BIM-22493, CAM 4072) is a cyclic peptide full agonist of melanocortin-4 receptor (MC4R) with an EC50 of 0.27 nM and a Ki of 2.1 nM.
P1108New Bremelanotide Acetate Bremelanotide Acetate (PT-141 Acetate) is a melanocortin receptor (MCR) agonist recently approved in the USA for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD), as characterized by low sexual desire that causes marked distress or interpersonal difficulty.
S0019 JNJ-10229570 JNJ-10229570 (UNII-N9IX402L35) is a potent MC1R and MC5R antagonist.
E1002New Setmelanotide (RM-493)

Setmelanotide (RM-493, BIM-22493, CAM 4072) is a cyclic peptide full agonist of melanocortin-4 receptor (MC4R) with an EC50 of 0.27 nM and a Ki of 2.1 nM.
P1108New Bremelanotide Acetate Bremelanotide Acetate (PT-141 Acetate) is a melanocortin receptor (MCR) agonist recently approved in the USA for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD), as characterized by low sexual desire that causes marked distress or interpersonal difficulty.
E1002New Setmelanotide (RM-493)

Setmelanotide (RM-493, BIM-22493, CAM 4072) is a cyclic peptide full agonist of melanocortin-4 receptor (MC4R) with an EC50 of 0.27 nM and a Ki of 2.1 nM.
Tags: Melanocortin Receptor inhibitor|Melanocortin Receptor agonist|Melanocortin Receptor activator|Melanocortin Receptor inducer|Melanocortin Receptor antagonist|Melanocortin Receptor signaling pathway|Melanocortin Receptor assay kit